SNGX

0.22018.29%
CJ

Christopher J. Schaber

Chairman of the Board of Directors, CEO & President

Dr. Christopher J. Schaber, Ph.D., is Trustee of BioNJ Inc. Dr. Schaber was Trustee of BioNJ Inc. until February 2019. Dr. Schaber has been the President and Chief Executive Officer at Soligenix, Inc. since August 30, 2006. Dr. Schaber has broad experience in the pharmaceutical and biotechnology industry. Dr. Schaber served from 1998 to 2006 as an Executive Vice President and Chief Operating Officer of Discovery Laboratories, Inc. He held positions of Executive Vice President of Drug Development and Regulatory Compliance since April 1999 and Chief Development Officer and Vice President of Regulatory Affairs and Quality Assurance Quality Control since June 1998. From 1996 to 1998, he was a co-founder of Acute Therapeutics, Inc. and served as its Vice President of Regulatory Compliance, Quality Assurance and Drug Development. Since January 2009, he has served on the board of directors of the Biotechnology Council of New Jersey (“BioNJ”). He served as a Director of Worldwide Regulatory Affairs and Operations for Ohmeda PPD, Inc. from 1994 to 1996. He held a variety of regulatory positions of increasing importance with Liposome Company, Inc. and Elkins-Sinn Inc., a division of Wyeth-Ayerst Laboratories from 1989 to 1994. Dr. Schaber also served as an NDA and FDA regulatory strategic advisor to DOR. He has been the Chairman of Soligenix, Inc. since October 8, 2009 and has been its Director since August 30, 2006. He has been the Chairman of BioNJ Inc. since February 2019 and served as its Vice Chairman. He also serves as a Director of Alliance for BioSecurity since October 2014. He also serves on the scientific advisory board for private start-up medical device company, Simphotek, Incorporated. He is a member of the corporate councils for both the National Organization for Rare Diseases (NORD) and the American Society for Blood and Marrow Transplantation (ASBMT) since October 2009 and July 2009, respectively. Dr. Schaber holds a Regulatory Affairs Certification (RAC) from Regulatory Affairs Professional Society. Dr. Schaber holds a B.A. from Western Maryland College and an M.S. in Pharmaceutics from Temple University and Ph.D. in Pharmaceutical Sciences from The Union Graduate School.

Positions